Form D Explorer
Avicenna Biosciences, Inc. · CIK 1824034

Report a data issueCitable research briefCompare issuerPrivate research collection

Avicenna Biosciences, Inc.

CIK 1824034 · Corporation · Inc. DELAWARE · DURHAM, North Carolina · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
0
Amendments
1
Activity
Oct 30, 2025
through Oct 30, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 30, 2025

Reported offering amount
$70,650
Reported exemptions
Rule 506(b)
Reported amount sold
$70,650

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)